Cost-effectiveness of midostaurin in the treatment of acute myeloid leukemia with the FLT3 mutation in Spain

  1. Arenaza, A.
  2. Diez, R.
  3. Esteve, J.
  4. Di Nicolantonio, R.
  5. Gostkorzewicz, J.
  6. Martínez, C.
  7. Llinàs, D.M.
  8. Martinez-Lopez, J.
  9. Montesinos, P.
  10. Moure-Fernández, A.
  11. Sierra, J.
  12. Vinent, J.L.
Aldizkaria:
ClinicoEconomics and Outcomes Research

ISSN: 1178-6981

Argitalpen urtea: 2019

Alea: 11

Orrialdeak: 683-694

Mota: Artikulua

DOI: 10.2147/CEOR.S222879 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus